Site-Specific Perturbations of Alpha-Synuclein Fibril Structure by the Parkinson's Disease Associated Mutations A53T and E46K

被引:47
|
作者
Lemkau, Luisel R. [1 ]
Comellas, Gemma [2 ]
Lee, Shin W. [1 ]
Rikardsen, Lars K. [1 ]
Woods, Wendy S. [3 ]
George, Julia M. [3 ]
Rienstra, Chad M. [1 ,2 ,4 ]
机构
[1] Univ Illinois, Dept Chem, Urbana, IL 61801 USA
[2] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA
[3] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL 61801 USA
[4] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA
来源
PLOS ONE | 2013年 / 8卷 / 03期
基金
美国国家卫生研究院;
关键词
SOLID-STATE NMR; PROTEIN SECONDARY STRUCTURE; ANGLE-SPINNING NMR; CHEMICAL-SHIFT; WILD-TYPE; AMYLOID FIBRILS; PHOSPHOLIPID-BINDING; CROSS-POLARIZATION; SPECTROSCOPY; RESOLUTION;
D O I
10.1371/journal.pone.0049750
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Parkinson's disease (PD) is pathologically characterized by the presence of Lewy bodies (LBs) in dopaminergic neurons of the substantia nigra. These intracellular inclusions are largely composed of misfolded alpha-synuclein (AS), a neuronal protein that is abundant in the vertebrate brain. Point mutations in AS are associated with rare, early-onset forms of PD, although aggregation of the wild-type (WT) protein is observed in the more common sporadic forms of the disease. Here, we employed multidimensional solid-state NMR experiments to assess A53T and E46K mutant fibrils, in comparison to our recent description of WT AS fibrils. We made de novo chemical shift assignments for the mutants, and used these chemical shifts to empirically determine secondary structures. We observe significant perturbations in secondary structure throughout the fibril core for the E46K fibril, while the A53T fibril exhibits more localized perturbations near the mutation site. Overall, these results demonstrate that the secondary structure of A53T has some small differences from the WT and the secondary structure of E46K has significant differences, which may alter the overall structural arrangement of the fibrils.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Parkinson's disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
    Zhao, Kun
    Li, Yaowang
    Liu, Zhenying
    Long, Houfang
    Zhao, Chunyu
    Luo, Feng
    Sun, Yunpeng
    Tao, Youqi
    Su, Xiao-dong
    Li, Dan
    Li, Xueming
    Liu, Cong
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [2] Parkinson’s disease associated mutation E46K of α-synuclein triggers the formation of a distinct fibril structure
    Kun Zhao
    Yaowang Li
    Zhenying Liu
    Houfang Long
    Chunyu Zhao
    Feng Luo
    Yunpeng Sun
    Youqi Tao
    Xiao-dong Su
    Dan Li
    Xueming Li
    Cong Liu
    Nature Communications, 11
  • [3] Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease
    Deusser, Janina
    Schmidt, Stefanie
    Ettle, Benjamin
    Ploetz, Sonja
    Huber, Sabine
    Mueller, Christian P.
    Masliah, Eliezer
    Winkler, Juergen
    Kohl, Zacharias
    JOURNAL OF NEUROCHEMISTRY, 2015, 135 (03) : 589 - 597
  • [4] Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T alpha-synuclein mutation
    Huang, Yue
    Chegini, Fariba
    Chua, Germaine
    Murphy, Karen
    Gai, Weiping
    Halliday, Glenda M.
    TRANSLATIONAL NEURODEGENERATION, 2012, 1
  • [5] Alpha-synuclein A53T mutation is not frequent on a sample of Brazilian Parkinson's disease patients
    Longo, Gabriela S.
    Pinhel, Marcela A. S.
    Gregorio, Michele L.
    Oliveira, Bruno A. P.
    Quinhoneiro, Driele C. G.
    Tognola, Waldir A.
    Oliveira, Fabio N.
    Cezario, Sabrina M.
    Sado, Caroline L.
    Nakazone, Marcelo A.
    Calastri, Maria C. J.
    Souza, Doroteia R. S.
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2015, 73 (06) : 506 - 509
  • [6] Controlling aggregation propensity in A53T mutant of alpha-synuclein causing Parkinson's disease
    Kumar, Sonu
    Sarkar, Anita
    Sundar, Durai
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (02) : 305 - 309
  • [7] Neuroprotection of α-synuclein under acute and chronic rotenone and maneb treatment is abolished by its familial Parkinson's disease mutations A30P, A53T and E46K
    Choong, Chi-Jing
    Say, Yee-How
    NEUROTOXICOLOGY, 2011, 32 (06) : 857 - 863
  • [8] Levodopa Rescues Retinal Function in the Transgenic A53T Alpha-Synuclein Model of Parkinson's Disease
    Tran, Katie K. N.
    Wong, Vickie H. Y.
    Vessey, Kirstan A.
    Finkelstein, David I.
    Bui, Bang V.
    Nguyen, Christine T. O.
    BIOMEDICINES, 2024, 12 (01)
  • [9] LRRK2 pathology in sporadic and alpha-synuclein A53T mutant Parkinson's disease
    Huang, Y.
    Gai, W.
    McCann, H.
    Halliday, G.
    MOVEMENT DISORDERS, 2006, 21 : S581 - S582
  • [10] Phase transitions and structure analysis in wild-type, A30P, E46K, and A53T mutants of α-synuclein
    Mark A. Healey
    Michael T. Woodside
    Jack A. Tuszynski
    European Biophysics Journal, 2016, 45 : 355 - 364